Judged on complexity and significance, the 2022 M&A Today Awards recognise our work in FeNO testing for airway inflammation, the biomarker of choice in point-of-care asthma treatment. Thanks go to our customers and colleagues for their continuing trust in FeNO by NIOX®.
Close Window
Important Safety Information | NIOX VERO® User Manual (PDF)
For Healthcare Professionals Only
Distributors
Give the best possible care to your asthma patients,
using NIOX® technology for simple diagnosis and
management.
Give the best possible care to your asthma patients, using NIOX® technology for simple diagnosis and management.
We are immensely proud to announce that on 2nd June 2021,
the healthcare community reached 40 million FeNO tests
completed with NIOX® technology.
We are immensely proud to announce that on 2nd June 2021, the healthcare community reached 40 million FeNO tests completed with NIOX® technology.
Accurately assess airway inflammation at the point-of-care with
NIOX, the gold standard FeNO analyser from Circassia, the world
leader in FeNO testing.
Accurately assess airway inflammation at the point-of-care with NIOX, the gold standard FeNO analyser from Circassia, the world leader in FeNO testing.
Join our online series of interactive webinars to hear the latest high quality education from the experts in asthma, FeNO and NIOX®.
Access our collection of informative articles, videos, podcasts and more to enhance your understanding of all things FeNO and NIOX®.
Join our online series of interactive webinars to hear the latest high quality education from the experts in asthma, FeNO and NIOX®.
Access our collection of informative articles, videos, podcasts and more to enhance your understanding of all things FeNO and NIOX®.
Join the thousands of healthcare professionals who have already performed over 40 million FeNO tests with NIOX®, and improve patient outcomes.
Visit our digital support hub to find the answers to any questions you might have about NIOX®, your order process and to contact Circassia.
